Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSCEND: VI-0106 in PAH with Functional Limitations
NCT07612657Phase 3Not yet recruiting
- Sponsor
- VIVUS
- Start
- May 2026
- Primary completion
- May 2028
01
Overview
A Phase 3 trial of tacrolimus in pulmonary arterial hypertension (PAH), sponsored by VIVUS. Planned start May 2026; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT07612657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07612657.